Jasper Therapeutics, Inc.·4

Jul 3, 4:20 PM ET

Lucas Svetlana 4

4 · Jasper Therapeutics, Inc. · Filed Jul 3, 2025

Insider Transaction Report

Form 4
Period: 2025-07-03
Transactions
  • Award

    Stock Option (right to buy)

    2025-07-03+7,5007,500 total
    Exercise: $6.77From: 2026-07-03Exp: 2035-07-03Voting Common Stock (7,500 underlying)
Footnotes (1)
  • [F1]Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders.

Documents

1 file
  • 4
    ownership.xmlPrimary